💫

PT-141

Bremelanotide · Vyleesi

High EvidenceSexual Wellness

FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women, with off-label research in men.

Half-Life

~2.7 hours

1025.2 Da

Amino Acids

7 AA

Evidence

High Evidence

Add to Protocol

Regulatory Status

FDA-approved (Vyleesi) for HSDD in premenopausal women. Research for male sexual dysfunction.

How it works: Add BAC water to your vial → calculator finds concentration → divides your dose by concentration → shows units to draw on a standard 100-unit insulin syringe. Values are pre-filled from research reference defaults — adjust to match your actual vial.

Vial Size (mg)

BAC Water (mL)

Dose (mcg)

fill level

Draw

17.5

units on a 100-unit syringe

= 0.175 mL

Conc.

10000

mcg/mL

Vol/dose

0.17

Doses/vial

inj.

Research reference values only. Confirm all parameters with current literature and your clinician.

Looking for multi-compound protocols?

Browse educational protocol discussions that include PT-141.

Protocol Library

Related Compounds

Kisspeptin

An endogenous neuropeptide and master regulator of the HPG axis, GnRH release, and reproductive function with significant clinical research interest.

Melanotan II

A cyclic alpha-MSH analogue with potent melanogenic, sexual arousal, and appetite-suppressing effects through broad melanocortin receptor activation.

Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.